Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells

Molecular Medicine Reports

Volumn 4, Issue 1, 2011, Pages 25-29

  Zhang, Yi ^a   Xu, Xiaoman ^a   He, Ping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

A549 human lung cancer cell line; Apoptosis; Tubeimoside 1

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; TUBEIMOSIDE 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BOLBOSTEMMA PANICULATUM; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; DOSE TIME EFFECT RELATION; DRUG STRUCTURE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LUNG CANCER; MEDICINAL PLANT; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CUCURBITACEAE; CYCLOOXYGENASE 2; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SAPONINS; TRITERPENES;

BOLBOSTEMMA PANICULATUM; CUCURBITACEAE;

EID: 78651406497     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.379     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun M: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
3. Erridge S, Moller H, Price A and Brewster D: International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol 4: 570-577, 2007 (Pubitemid 47534756)
4. Fernando JR, Eva ER, José AL and Marta C: Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway. Cancer Lett 273: 44-54, 2009.
5. Li Y, Carl-Magnus B and Lars-Arne H: Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells. Eur J Pharmacol 609: 13-18, 2009.
6. Zhang XH, Sun NX, Guo RX, Xing JL and Liu XN: Efficacy research of tubeimoside against the experimental herpes simplex keratitis. Rec Adv Ophthalmol 22: 373-376, 2002.
7. Yu TX, Ma RD and Yu LJ: Structure-activity relationship of tubeimosides in anti-inflammatory, antitumor, and antitumor-promoting effects. Acta Pharmacologica Sinica 22: 463-468, 2001.
8. Li XH, Wang P and Fu ZC: Effects of Bolbastemmosaponins A on immunologic functions of experimental animals. China Pharm 9: 13, 1998.
9. Wang YQ, Yu LJ, Zhu JL and Yang SY: Studies on antitumor action of extracts of Bolbostemma paniculatum (Maxim.) Franquet. Shaanxi Med J 10: 55, 1981.
10. Kong F, Zhu D, Xu R, Fu Z, Zhou L, Iwashita T and Komura H: Structural study of tubeimoside I, a constituent of tubei-mo. Tetrahedron Lett 27: 5765, 1986.
11. Chi-Tai Y, Yerra KR and Chih-Jung Y: Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Lett 285: 73-79, 2009.
12. Edderkaoui M, Odinokova I, Ohno I, Gukovsky I, Go VL, Pandol SJ and Gukovskaya AS: Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J Gastroenterol 14: 3672-3680, 2008.
13. Wang F, Ma RD and Yu LJ: Role of mitochondria and mitochondrial cytochrome c in tubeimoside I-mediated apoptosis of human cervical carcinoma HeLa cell line. Cancer Chemother Pharmacol 57: 389-399, 2006.
14. Liu WY, Zhang WD and Chen HS: New triterpenoid saponins from bulbs of Bolbostemma paniculatum. Planta Med 70: 458-464, 2004 (Pubitemid 38716481)
15. Liang MJ, Zhang WD and Zhang C: Quantitative determination of the anticancer agent tubeimoside I in rat plasma by liquid chromatography coupled with mass spectrometry. J Chromatogr B 845: 84-89, 2007. (Pubitemid 44839300)
16. Ma RD, Song G and You WB: Anti-microtubule activity of tubeimoside I and its colchicinebinding site of tubulin. Cancer Chemother Pharmacol 62: 559-568, 2008.
17. Oltersdorf T, Elmore SW and Shoemaker AR: An inhibitor of Bcl-2 family proteins induces regression of solid tumors. Nature 435: 677-681, 2005. (Pubitemid 40825512)
18. Metrailler-Ruchonnet I, Pagano A and Carnesecchi S: Bcl-2 protects against hyperoxia-induced apoptosis through inhibition of the mitochondria-dependent pathway Free Radic Biol Med 42: 1062-1074, 2007.
19. Yao Y, Huang C, Li ZF, Wang AY: Exogenous phosphatidylethanolamine induces apoptosis of human hepatoma HepG2 cells via the bcl-2/bax pathway. World J Gastroenterol 15: 1751-1758, 2009.
20. Jiang TS, Zhou LP and Zhang WL: Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro. Mol Med Rep 3: 51-56, 2010.
21. Ren G, Zhao YP, Yang L and Fu CX: Anti-proliferative effect of clitocine from the mushroom Leucopaxillus giganteus on human cervical cancer HeLa cells by inducing apoptosis. Cancer Lett 262: 190-200, 2008.
22. Koehne CH and Dubois RN: COX-2 inhibition and colorectal cancer. Semin Oncol 31: 12-21, 2004
23. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ and Seibert K. Antiangiogenic and antitumor activities of Cyclooxygenase-2 inhibitors. Cancer Res 60: 1306-1311, 2000. (Pubitemid 30151999)
24. Tsubochi H, Nobuyuki S and Hiyama M: Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer. Ann Thorac Surg 82: 1198-1204, 2006. (Pubitemid 44402329)
25. Petkova DK, Clelland C, Ronan J, Pang L, Coulson JM, Lewis S and Knox AJ: Overexpression of cyclooxygenase-2 in non-small cell lung cancer. Respir Med 98: 164-172, 2004 (Pubitemid 38181136)
26. Brown JR and DuBois RN: Cyclooxygenase as a target in lung cancer. Clin Cancer Res 10: 4266-4269, 2004
27. Brabender J, Park J and Metzger R: Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer. Ann Surg 235: 440-443, 2002. (Pubitemid 34183896)
28. Hasturk S, Kemp B and Kalapurakal SK: Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Cancer 94: 1023-1031, 2002. (Pubitemid 34150857)
29. Hosomi Y, Yokose T and Hirose Y: Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 30: 73-81, 2000.
30. Eibl G, Takata Y and Boros LG: Growth stimulation of COX-2 negative pancreatic cancer by a selective Cox-2 inhibitor. Cancer Res 65: 982-990, 2005. (Pubitemid 40216460)
31. Chun K and Surh Y: Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemo-prevention. Biochem Pharm 68: 1089-1100, 2004 (Pubitemid 39099277)
32. Gasparini G, Longo R and Sarmiento R: Inhibitors of cyclooxygenase-2: a new class of anticancer agents? Lancet 4 605-615, 2003.
33. Sheng H, Shao J, Morrow JD, Beauchamp RD and DuBois RN: Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58: 362-366, 1998. (Pubitemid 28047080)